Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).

@article{Lee2012ComparisonOE,
  title={Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).},
  author={Cheol Whan Lee and Su-Jin Kang and Jung Min Ahn and Hae Geun Song and Jong-Young Lee and Won Jang Kim and Duk Woo Park and Seung Whan Lee and Young-Hak Kim and Seong-wook Park and Seung-jung Park},
  journal={The American journal of cardiology},
  year={2012},
  volume={109 12},
  pages={1700-4}
}
High-dose rosuvastatin induces regression of coronary atherosclerosis, but it remains uncertain whether usual-dose statin has similar effects. We compared the effects of atorvastatin 20 mg/day versus rosuvastatin 10 mg/day on mild coronary atherosclerotic plaques (20% to 50% luminal narrowing and lesion length >10 mm) using intravascular ultrasound (IVUS). Three hundred fifty statin-naive patients with mild coronary atherosclerotic plaques were randomized to receive atorvastatin 20 mg/day or… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

2017 Taiwan lipid guidelines for high risk patients.

Journal of the Formosan Medical Association = Taiwan yi zhi • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…